Carboplatin alone not adequate for ovarian cancer in frail seniors
(HealthDay)—For vulnerable older patients with ovarian cancer, single-agent carboplatin is less active, with worse survival, than combination carboplatin-paclitaxel regimens, according to a study published online April ...
Apr 27, 2021
0
2